About Us
Our goal at Drug Dangers is to help keep the public educated and informed of defective medical devices and dangerous medications that are currently on the market. As an online resource sponsored by Seeger Weiss LLP, Drug Dangers strives to provide accurate, relevant medical information all in one place. Under the unfortunate circumstance that you or a loved one has been injured by faulty medications or devices, fill out a form or give us a call today.
Who We Are
The Seeger Weiss firm currently numbers approximately 20 attorneys operating out of offices in New York City, NY; Ridgefield Park, NJ; and Philadelphia, PA. It focuses on mass tort and class action litigation, with particular emphasis in the areas of products liability, pharmaceutical injury, consumer protection, environmental and toxic tort, securities fraud, antitrust, insurance, ERISA, employment, and qui tam litigation.
Founding partner, Chris Seeger, began his career representing corporate interests through a variety of bankruptcy and commercial litigation lawsuits. Seeger took notice of how many individuals were being victimized by corporate abuse and malfeasance and therefore decided to shift his focus to these individuals in pursuit of justice. In his shift to the plaintiff’s bar, he began his own practice which would in time become Seeger Weiss.
Our Team
Located in New York, Ridgefield, and Philadelphia. Our attorneys represent plaintiffs in personal injury, drug & medical device injury, product liability, environmental, consumer fraud, qui tam, class action, mass tort and commercial litigation claims. The firm has been at the forefront of developing creative theories of liability in the ever-changing litigation landscape.
Contact Us
Our attorneys represent plaintiffs in personal injury claims, asbestos injury cases, mesothelioma injury cases, environmental, consumer fraud, qui tam, class action suits, mass tort litigation and commercial litigation. The firm has been in the forefront of developing creative theories of liability in the ever-changing litigation landscape.
